Visual dysfunction is associated with cognitive impairment in Parkinson's disease
Rocío Del Pino1, Marian Acera1, Ane Murueta-Goyena1
1Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.
Parkinsonism & Related Disorders
|October 18, 2021
Summary
Visual impairments significantly impact cognitive abilities in Parkinson's disease (PD). Assessing lower-level visual functions like acuity is crucial for understanding and predicting cognitive decline in PD patients.
Area of Science:
- Neuroscience
- Ophthalmology
- Cognitive Science
Background:
- Parkinson's disease (PD) frequently involves visual dysfunction and cognitive impairment.
- The specific link between basic visual deficits and cognition in PD remains underexplored.
Purpose of the Study:
- To investigate the association between lower-level visual functions and cognitive performance in Parkinson's disease.
- To determine if visual acuity and contrast sensitivity predict cognitive status in PD.
Main Methods:
- 49 Parkinson's disease patients and 22 healthy controls were assessed.
- Evaluated high and low contrast visual acuity (HCVA, LCVA), contrast sensitivity (CS), and visual cognition.
- Used correlation and regression analyses to link visual function to cognitive performance.
Main Results:
- PD patients showed impairments in cognition and lower-level visual functions compared to controls.
- High and low contrast visual acuity were significantly associated with various cognitive domains.
- HCVA explained substantial variance in visual perception and visuospatial abilities.
Conclusions:
- Lower-level visual dysfunction is strongly linked to cognitive performance in Parkinson's disease.
- Visual function assessment is vital for evaluating PD cognitive status and predicting decline.
Related Concept Videos
01:15Parkinson's Disease: Overview
840
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
840
01:12Visual Agnosia
457
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
457
01:22Photoreceptors and Visual Pathways
6.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.8K
01:24Parkinson's Disease: Treatment
444
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
444
01:26Alzheimer's Disease: Overview
750
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
750
01:24Prosopagnosia
380
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
380